Antibody drug conjugates market is estimated to be worth more than 15 billion in 2030, predicts Roots Analysis
Report Keywords – Antibody Drug, Conjugates, Roots Analysis, Biotech, Analysis   Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community   Roots Analysis is pleased to announce the publication of its...
0 Commentaires 0 Parts